Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Endocrinology · Prolactinoma

What Is a Prolactinoma? Building Your Foundation

At a Glance

A prolactinoma is a benign (non-cancerous) tumor on the pituitary gland that produces too much prolactin hormone. It is the most common type of pituitary tumor and is typically treated effectively with daily medication to shrink the tumor and reverse symptoms, rather than surgery.

Receiving a diagnosis that involves the word “tumor” and “brain” is understandably frightening. However, it is important to take a deep breath and look at the facts. A prolactinoma is a non-cancerous (benign) growth on your pituitary gland, a pea-sized organ at the base of your brain that controls many of your body’s hormones [1][2].

While it is technically a brain tumor because of its location, it is not “brain cancer” [1]. Prolactinomas are actually the most common type of pituitary tumor [1]. They cause problems not because they are aggressive or invasive like cancer, but because they produce too much prolactin—the hormone responsible for milk production and regulating the reproductive system [3][4].

Grounding Facts for Your Journey

When you are first diagnosed, your mind may jump to the worst-case scenario. These three facts can help stabilize your perspective:

  1. It is benign, not cancerous. Prolactinomas do not spread to other parts of the body [1][2].
  2. It is usually treated with pills, not surgery. Unlike many other tumors, the first-line treatment for most prolactinomas is medication (called dopamine agonists) that can normalize your hormone levels and even shrink the tumor [5][6].
  3. Your symptoms are reversible. Issues like loss of libido, erectile dysfunction, or fertility challenges are directly caused by the hormone imbalance [7][8]. Once the prolactin level is controlled, these symptoms typically resolve [7][9].

Understanding Size and Classification

Doctors classify prolactinomas primarily by their size, which helps determine the treatment plan and what symptoms you might experience:

  • Microprolactinoma: These are small tumors, less than 10 millimeters (1 cm) in diameter [10]. They are the most common and often only cause hormonal symptoms.
  • Macroprolactinoma: These are 10 millimeters or larger [10]. Because of their size, they can sometimes press on nearby structures like the optic nerves, potentially causing vision changes or headaches [11].
  • Giant Prolactinoma: A rare subtype measuring 40 millimeters (4 cm) or larger [10]. These require more intensive monitoring but can still respond well to medical therapy [1].

Validating Your Experience

It is completely normal to feel “broken” or deeply anxious after this diagnosis. Research shows that high prolactin levels are directly linked to increased anxiety, sleep disorders, and a lower sense of “self-efficacy”—the feeling that you are capable of managing your life [12].

The hormone itself can alter your mood and quality of life [13]. If you feel more emotional, irritable, or exhausted than usual, know that these are medically recognized effects of the condition, not a personal failing [13][12]. As your treatment progresses and your hormone levels normalize, most patients find that their quality of life and emotional stability return to their normal baseline [13].

How Treatment Works

The goal of treatment is twofold: to bring your prolactin levels back to a healthy range and to shrink the tumor [6].

  • Medication: Most patients start with drugs like cabergoline or bromocriptine. These mimic dopamine in the brain, which tells the pituitary gland to stop producing so much prolactin [5][6]. Common physical side effects when first starting include nausea and dizziness, but these usually improve.
  • Surgery: While less common as a first step, surgery may be an option if medications cause too many side effects or if the tumor does not respond to the pills [11][14].
  • Monitoring: You will likely have regular blood tests to check your prolactin levels and occasional MRI scans to monitor the size of the tumor [15][16].

Back to Home

Common questions in this guide

Is a prolactinoma considered brain cancer?
No, a prolactinoma is a benign, non-cancerous growth on the pituitary gland. While it is located at the base of the brain, it is not aggressive and does not spread to other parts of the body like cancer does.
What is the difference between a microprolactinoma and a macroprolactinoma?
A microprolactinoma is a small tumor measuring less than 10 millimeters, which usually only causes hormonal symptoms. A macroprolactinoma measures 10 millimeters or larger and can sometimes press on nearby structures, potentially causing vision changes or headaches.
Will I need surgery to treat my prolactinoma?
Most prolactinomas do not require surgery and are treated first with medications called dopamine agonists. These drugs can effectively normalize your hormone levels and shrink the tumor. Surgery is usually only considered if medications cause severe side effects or fail to shrink the tumor.
Can a prolactinoma affect my mood or mental health?
Yes, high prolactin levels are directly linked to increased anxiety, sleep disorders, and emotional irritability. These mood changes are recognized medical effects of the hormone imbalance and typically improve as your treatment normalizes your prolactin levels.
Will my fertility and libido improve with treatment?
Symptoms like low libido, erectile dysfunction, or fertility challenges are directly caused by the hormone imbalance. Once your prolactin levels are controlled by medication, these symptoms typically resolve.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I dealing with a microprolactinoma or a macroprolactinoma, and what is its exact size in millimeters?
  2. 2.What was my prolactin level at diagnosis, and what is our target goal for that number?
  3. 3.Given my specific tumor size, are you recommending medication as the first-line treatment, and why?
  4. 4.How soon can I expect my hormone-related symptoms, like low libido or fertility issues, to begin improving?
  5. 5.What behavioral or mood changes should I watch for once I start taking a dopamine agonist?
  6. 6.If we start with medication, how will we monitor whether the tumor is shrinking?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Prolactinoma: Navigating the Dual Challenge of Side Effects and Treatment Strategies - A Comprehensive Review.

    Yogeeta F, Rauf SA, Devi M, et al.

    Annals of medicine and surgery (2012) 2024; (86(8)):4613-4623 doi:10.1097/MS9.0000000000002308.

    PMID: 39118737
  2. 2

    Spectrum of Pituitary disorders: A retrospective study from Basrah, Iraq.

    Mansour AA, Alhamza AHA, Almomin AMSA, et al.

    F1000Research 2018; (7()):430 doi:10.12688/f1000research.13632.2.

    PMID: 30026929
  3. 3

    [Current diagnosis and treatment of hyperprolactinemia].

    Melgar V, Espinosa E, Sosa E, et al.

    Revista medica del Instituto Mexicano del Seguro Social 2016; (54(1)):111-21.

    PMID: 26820213
  4. 4

    Overview of Hyperprolactinemia: General Approach and Reproductive Health Implications.

    Haidenberg-David F, Sidauy-Adissi J, Moscona-Nissan A, et al.

    Archives of medical research 2024; (55(8)):103102 doi:10.1016/j.arcmed.2024.103102.

    PMID: 39454469
  5. 5

    Management outcomes of prolactinoma: a retrospective study from Southern Iraq.

    Alobaidy HF, Alidrisi HA, Reman KA, et al.

    Journal of medicine and life 2025; (18(9)):869-877 doi:10.25122/jml-2025-0050.

    PMID: 41178903
  6. 6

    Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline.

    Astaf'eva L, Shishkina L, Kalinin P, et al.

    Asian journal of neurosurgery 2020; (15(2)):385-390 doi:10.4103/ajns.AJNS_16_20.

    PMID: 32656137
  7. 7

    Prolactinoma and pregnancy: From the wish of conception to lactation.

    Maiter D

    Annales d'endocrinologie 2016; (77(2)):128-34.

    PMID: 27130071
  8. 8

    Prolactin impairs erectile function via eNOS suppression independently of testosterone.

    Cheng X, Xiao Y, Qiu D, et al.

    Toxicology and applied pharmacology 2025; (504()):117532 doi:10.1016/j.taap.2025.117532.

    PMID: 40848920
  9. 9

    True hyperprolactinemia in men without visible pituitary adenoma.

    Shimon I, Rudman Y, Manisterski Y, et al.

    Endocrine 2021; (72(3)):809-813 doi:10.1007/s12020-021-02624-1.

    PMID: 33566310
  10. 10

    Therapeutic challenges of giant invasive cystic macroprolactinoma.

    Mekni S, Khiari H, Bouali S, et al.

    Endocrinology, diabetes & metabolism case reports 2025; (2025(4)).

    PMID: 41294385
  11. 11

    The Role of Surgery in the Management of Prolactinomas.

    Donoho DA, Laws ER

    Neurosurgery clinics of North America 2019; (30(4)):509-514 doi:10.1016/j.nec.2019.05.010.

    PMID: 31471058
  12. 12

    A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma.

    Miao X, Fu Z, Luo X, et al.

    Frontiers in endocrinology 2024; (15()):1369729 doi:10.3389/fendo.2024.1369729.

    PMID: 38572480
  13. 13

    Quality of life in Prolactinoma: A systematic review.

    Castle-Kirszbaum M, Biermasz N, Kam J, Goldschlager T

    Pituitary 2024; (27(3)):239-247 doi:10.1007/s11102-024-01392-1.

    PMID: 38656635
  14. 14

    Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery.

    Bakker LEH, Verstegen MJT, Ghariq E, et al.

    Pituitary 2022; (25(4)):587-601 doi:10.1007/s11102-022-01230-2.

    PMID: 35616762
  15. 15

    Diagnosis and management of prolactinomas: current challenges.

    Petersenn S, Giustina A

    Pituitary 2020; (23(1)):1-2 doi:10.1007/s11102-019-01025-y.

    PMID: 31900881
  16. 16

    Correlation between MRI findings of pituitary gland and prolactin level among hyperprolactinemia adult female Saudi patients in rural areas: A retrospective multicentric study.

    Alyami N, Alhenaki G, Al Atwah S, et al.

    Medicine 2025; (104(2)):e40686 doi:10.1097/MD.0000000000040686.

    PMID: 39792709

This page provides educational information about prolactinomas and does not replace professional medical advice. Always consult your endocrinologist or healthcare provider for specific treatment recommendations and medical guidance.

Get notified when new evidence is published on prolactin producing pituitary tumor.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.